B. Braun announces the FDA emergency use authorization of the Perfusor Space Syringe Infusion Pump, Infusomat Space Volumetric Infusion Pump, and Outlook ES Pump systems. These are to be used for tracheal delivery of continuous nebulized medications into a nebulizer to treat patients of all ages with or suspected of having COVID-19 and to decrease the exposure of health care providers to these patients during the pandemic. This authorization allows an alternative method for administering continuous nebulized medications to patients who are critically ill with COVID-19, many of whom are on ventilation.
B. Braun Medical Inc
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.